 |  | Valeant to buy 'female Viagra' maker Sprout Pharma |  | (Reuters) - Canada's Valeant Pharmaceuticals International Inc said it would buy privately owned Sprout Pharmaceuticals, whose drug became the first approved treatment this week for low sexual desire in women, for about $1 billion plus milestone payments. | |  | Valeant CEO says was in talks with Sprout for three weeks |  | NEW YORK (Reuters) - Valeant Pharmaceuticals International Chief Executive J. Michael Pearson said Thursday on CNBC the company had been in talks to buy female libido drug company Sprout Pharmaceuticals for about three weeks prior to signing the $1 billion deal. | |  |  |  | Growth fears hit stocks, oil, emerging markets |  | LONDON (Reuters) - Stocks, oil and emerging market currencies fell on Thursday as fading expectations for an imminent U.S. interest rate hike stoked anxiety about the health of the global economy. | |  |  |  | Howard Buffett bets on hydropower to rebuild eastern Congo |  | MATEBE, Democratic Republic of Congo (Reuters) - U.S. philanthropist Howard Buffett, son of billionaire investor Warren, is pouring millions of dollars into power projects in war-torn Congo, betting that private investment can bring development where the United Nations and aid agencies failed. | |  |  |  | U.S. crude prices fall towards $40 on global glut |  | LONDON (Reuters) - U.S. crude oil prices fell to almost $40 a barrel on Thursday, their lowest since the global financial crisis of 2009, as supplies rose in North America and the Middle East, filling stockpiles to record levels. | |  |  |  | Fed's Kocherlakota floats increase in U.S. inflation target |  | (Reuters) - A top U.S. central banker on Thursday floated the possibility of increasing the Federal Reserve's inflation target as a way to reduce financial stability risks and make it easier for the Fed to achieve price stability and full employment. | |  | |  |  | |  |  | Related Video | |  | |  | |  |  |  |  |  | Make sense of the market with highlights of valuable financial information and reports along with compelling investment insights. Register Today |  | |  |  |  | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today |  | |  | » » MORE NEWSLETTERS |  | |
No comments:
Post a Comment